Maryland 2025 2025 Regular Session

Maryland Senate Bill SB224 Engrossed / Bill

Filed 01/28/2025

                     
 
EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. 
        [Brackets] indicate matter deleted from existing law. 
         Underlining indicates amendments to bill. 
         Strike out indicates matter stricken from the bill by amendment or deleted from the law by 
amendment. 
          *sb0224*  
  
SENATE BILL 224 
J1   	5lr0265 
  	(PRE–FILED) 	CF HB 94 
By: Chair, Finance Committee (By Request – Departmental – Health) 
Requested: October 6, 2024 
Introduced and read first time: January 8, 2025 
Assigned to: Finance 
Committee Report: Favorable 
Senate action: Adopted 
Read second time: January 24, 2025 
 
CHAPTER ______ 
 
AN ACT concerning 1 
 
Opioid–Associated Disease Prevention and Outreach Programs – Appeals and 2 
Membership of Standing Advisory Committee 3 
 
FOR the purpose of authorizing a local health department or community –based 4 
organization to appeal to the Secretary of Health or the Secretary’s designee, rather 5 
than to the Deputy Secretary for Public Health Services, an adverse decision of the 6 
Maryland Department of Health and a local health officer regarding an application 7 
for authorization to operate an Opioid–Associated Disease Prevention and Outreach 8 
Program; altering the membership of the Standing Advisory Committee on 9 
Opioid–Associated Disease Prevention and Outreach Programs; and generally 10 
relating to Opioid–Associated Disease Prevention and Outreach Programs. 11 
 
BY repealing and reenacting, without amendments, 12 
 Article – Health – General 13 
Section 24–901(a) and (f) 14 
 Annotated Code of Maryland 15 
 (2023 Replacement Volume and 2024 Supplement) 16 
 
BY repealing and reenacting, with amendments, 17 
Article – Health – General 18 
Section 24–902, 24–904, and 24–905 19 
Annotated Code of Maryland 20 
(2023 Replacement Volume and 2024 Supplement) 21 
  2 	SENATE BILL 224  
 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 1 
That the Laws of Maryland read as follows: 2 
 
Article – Health – General 3 
 
24–901. 4 
 
 (a) In this subtitle the following words have the meanings indicated. 5 
 
 (f) “Program” means an Opioid–Associated Disease Prevention and Outreach 6 
Program. 7 
 
24–902. 8 
 
 (a) (1) A Program may be established by a local health department or a 9 
community–based organization, subject to the provisions of this subtitle. 10 
 
 (2) (i) A county may cooperate with another county to establish a 11 
Program. 12 
 
 (ii) A community–based organization may establish a multicounty 13 
Program. 14 
 
 (3) This subtitle does not apply to the AIDS Prevention Sterile Needle and 15 
Syringe Exchange Pilot Program established under Subtitle 8 of this title. 16 
 
 (b) (1) (i) A local health department or community–based organization 17 
shall apply to the Department and a local health officer for authorization to operate a 18 
Program. 19 
 
 (ii) A local health department or community–based organization 20 
may apply at any time for authorization to operate a Program under subparagraph (i) of 21 
this paragraph. 22 
 
 (2) The Department and a local health officer jointly shall issue an 23 
authorization determination based on the ability of a Program to meet the requirements of 24 
this subtitle. 25 
 
 (3) The Department and a local health officer shall: 26 
 
 (i) Approve or deny an application for authorization to operate a 27 
Program within 60 days after receiving a complete application; and 28 
 
 (ii) Provide to the applicant a written explanation of the decision of 29 
the Department and local health officer. 30 
   	SENATE BILL 224 	3 
 
 
 (4) (i) A local health department or community–based organization 1 
may appeal an adverse decision by the Department and a local health officer to the 2 
[Deputy] Secretary [for Public Health Services] OR THE SECRETARY’S DESIGNEE. 3 
 
 (ii) The [Deputy] Secretary OR THE SECRETARY’S DESIGNEE 4 
shall: 5 
 
 1. Grant or deny an appeal within 60 days after receiving an 6 
appeal; and 7 
 
 2. Provide a written explanation of the [Deputy] Secretary’s 8 
OR THE SECRETARY’S DESIGNEE’S decision to the local health department or 9 
community–based organization. 10 
 
 (c) If established under subsection (a) of this section, a Program shall: 11 
 
 (1) Provide for substance use outreach, education, and linkage to treatment 12 
services to participants, including distribution and collection of hypodermic needles and 13 
syringes; and 14 
 
 (2) Operate in accordance with: 15 
 
 (i) The technical assistance of the Standing Advisory Committee; 16 
and 17 
 
 (ii) The procedures, plans, and protocols approved by: 18 
 
 1. The local health officer for each county in which a Program 19 
is established; and 20 
 
 2. The Department. 21 
 
24–904. 22 
 
 (a) The Department shall appoint a Standing Advisory Committee on 23 
Opioid–Associated Disease Prevention and Outreach Programs. 24 
 
 (b) The Standing Advisory Committee shall consist of: 25 
 
 (1) The [Deputy] Secretary [for Public Health Services] OR THE 26 
SECRETARY’S DESIGNEE; 27 
 
 (2) One individual from academia who specializes in public health issues 28 
related to substance–related disorders or infectious diseases; 29 
  4 	SENATE BILL 224  
 
 
 (3) One representative from law enforcement, nominated by the Executive 1 
Director of the Governor’s Office of Crime Prevention and Policy; 2 
 
 (4) One individual with expertise in the prevention of HIV or viral 3 
hepatitis; 4 
 
 (5) One health care practitioner with experience providing services to 5 
individuals who inject drugs; 6 
 
 (6) One individual with substance use experience; 7 
 
 (7) One family member of an individual who injects or has injected drugs; 8 
 
 (8) One representative of local law enforcement; 9 
 
 (9) One local health officer; 10 
 
 (10) One representative of a local or regional hospital; 11 
 
 (11) One individual with experience in syringe services programs; and 12 
 
 (12) Any additional members recommended by the Department. 13 
 
 (c) The [Deputy] Secretary [for Public Health Services] OR THE SECRETARY’S 14 
DESIGNEE shall serve as chair of the Standing Advisory Committee. 15 
 
 (d) The Standing Advisory Committee shall: 16 
 
 (1) Provide technical assistance to each Program on developing: 17 
 
 (i) Program operating procedures for collection and distribution of 18 
hypodermic needles and syringes; 19 
 
 (ii) A plan for community outreach and education; and 20 
 
 (iii) A protocol for linking Program participants to substance–related 21 
disorder treatment and recovery services; and 22 
 
 (2) Make recommendations to a Program regarding any aspect of Program 23 
procedures or operation. 24 
 
24–905. 25 
 
 (a) The Department shall: 26 
   	SENATE BILL 224 	5 
 
 
 (1) Adopt regulations for the implementation of this subtitle, in 1 
consultation with the Standing Advisory Committee and the Maryland Association of 2 
County Health Officers; and 3 
 
 (2) Ensure the provision of technical assistance to a Program about best 4 
practices, best practice protocols, and other subject areas. 5 
 
 (b) The regulations adopted under subsection (a)(1) of this section shall establish: 6 
 
 (1) Procedures for ensuring the security of Program locations and 7 
equipment; 8 
 
 (2) An appeals process for appeals authorized by § 24–902(b)(4) of this 9 
subtitle, including the standard of review that the [Deputy] Secretary [for Public Health 10 
Services] OR THE SECRETARY’S DESIGNEE must apply when reviewing a decision of the 11 
Department and a local health officer; and 12 
 
 (3) Procedures for data collection and Program evaluation. 13 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 14 
1, 2025. 15 
 
 
 
 
Approved: 
________________________________________________________________________________  
 Governor. 
________________________________________________________________________________  
         President of the Senate. 
________________________________________________________________________________  
  Speaker of the House of Delegates.